Skip to main content
Top
Appendix
Available only for authorised users
Literature
1.
go back to reference Mobius-Winkler S, Majunke N, Sandri M et al (2015) Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the watchman device. World J Cardiol 7:65–75CrossRefPubMedPubMedCentral Mobius-Winkler S, Majunke N, Sandri M et al (2015) Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the watchman device. World J Cardiol 7:65–75CrossRefPubMedPubMedCentral
2.
go back to reference Gloekler S, Shakir S, Doblies J et al (2015) Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 104(8):656–665CrossRefPubMed Gloekler S, Shakir S, Doblies J et al (2015) Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 104(8):656–665CrossRefPubMed
3.
go back to reference Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229CrossRefPubMed Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229CrossRefPubMed
4.
go back to reference Viles-Gonzalez JF, Kar S, Douglas P et al (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 59:923–929CrossRefPubMed Viles-Gonzalez JF, Kar S, Douglas P et al (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 59:923–929CrossRefPubMed
6.
go back to reference Saia F, Martinez C, Gafoor S et al (2015) Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv 8:681–688CrossRefPubMed Saia F, Martinez C, Gafoor S et al (2015) Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv 8:681–688CrossRefPubMed
7.
go back to reference Smolka G, Pysz P, Jasinski M et al (2015) Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: a prospective registry. Catheter Cardiovasc Interv. doi:10.1002/ccd.25992 PubMed Smolka G, Pysz P, Jasinski M et al (2015) Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: a prospective registry. Catheter Cardiovasc Interv. doi:10.​1002/​ccd.​25992 PubMed
Metadata
Title
Percutaneous closure of an incomplete left atrial appendage closure
Authors
Manuel Viehmann
Ingo Dähnert
Gerhard Schuler
Marcus Sandri
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 9/2016
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-0982-0

Other articles of this Issue 9/2016

Clinical Research in Cardiology 9/2016 Go to the issue